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Introduction: In April 2019, an HIV-1 outbreak among children occurred in Larkana,
Pakistan, affecting more than a thousand children. It was assumed that the outbreak
originated from a single source, namely a doctor at a private health facility. In this study,
we performed subtype distribution, phylogenetic and drug-resistance analysis of HIV-1
sequences from 2019 outbreak in Larkana, Pakistan.
Methods: A total of 401 blood samples were collected between April–June 2019, from
children infected with HIV-1 aged 0–15 years recruited into a case-control study to
investigate the risk factors for HIV-1 transmission. Partial HIV-1 pol sequences were
generated from 344 blood plasma samples to determine HIV-1 subtype and drug
resistance mutations (DRM). Maximum-likelihood phylogenetics based on outbreak
and reference sequences was used to identify transmission clusters and assess the
relationship between outbreak and key population sequences between and within the
determined clusters. Bayesian analysis was employed to identify the time to the most
recent common recent ancestor (tMRCA) of the main Pakistani clusters.
Results: The HIV-1 circulating recombinant form (CRF) 02_AG and subtype A1 were
most common among the outbreak sequences. Of the treatment-naïve participants,
the two most common mutations were RT: E138A (8%) and RT: K219Q (8%). Four
supported clusters within the outbreak were identified, and the median tMRCAs of the
Larkana outbreak sequences were estimated to 2016 for both the CRF02_AG and
the subtype A1 clusters. Furthermore, outbreak sequences exhibited no phylogenetic
mixing with sequences from other high-risk groups of Pakistan.
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Conclusion: The presence of multiple clusters indicated a multi-source outbreak, rather
than a single source outbreak from a single health practitioner as previously suggested.
The multiple introductions were likely a consequence of ongoing transmission within
the high-risk groups of Larkana, and it is possible that the so-called Larkana
strain was introduced into the general population through poor infection prevention
control practices in healthcare settings. The study highlights the need to scale up
HIV-1 prevention programmes among key population groups and improving infection
prevention control in Pakistan.
Keywords: HIV-1, outbreak investigation, phylogenetic analysis, drug resistance, paediatric [MeSH]
INTRODUCTION
The HIV-1 pandemic has been established for 40 years and has
resulted in approximately 32.7 million deaths worldwide (de
Mendoza, 2019). One of the characteristic features of HIV-1
is its high mutation rate and recombination rate within and
between hosts, leading to the emergence of distinct subtypes
and circulating recombinant forms (CRFs) (Taylor et al., 2008;
van Zyl et al., 2018). The subtypes can also recombine to
give rise to unique recombinant forms (URFs) and minor
HIV-1 variants (Taylor et al., 2008). The consequent genetic
diversity that characterises HIV-1 infection has implications for
virological control and transmission. Mutations encoded by the
virus can interfere with epitope processing and recognition,
leading to immune evasion. In addition, mutations may also
lead to resistance to anti-retroviral drugs (van Zyl et al., 2018).
Furthermore, certain immune- or drug-escape mutations may
facilitate rapid transmission (van Zyl et al., 2018).
The phylogenetic and phylodynamic analysis of sequences
derived from people living with HIV-1 (PLWH), particularly
those who are part of an outbreak, can help answer
fundamental questions such as the directionality and pattern
of transmission and in understanding the introduction of
HIV-1 into different regions, as well as identify clusters of
transmission (Kosakovsky Pond et al., 2018; Dawson et al., 2020;
Romero-Severson et al., 2020).
Pakistan has experienced a growing HIV-1 epidemic that is
concentrated among three key population groups namely persons
who inject drugs (PWID), transgender sex workers [also known
as Hijra sex workers (HSW)], and men who have sex with men
(MSM) (Raees et al., 2013) in whom prevalence is around 38–40,
11, and 7.5%, respectively (Baqi et al., 1998; Waheed and Waheed,
2017; Hasan et al., 2018). Only 36,000 of an estimated 160,000
PLWH in Pakistan were aware of their HIV-1 positive status in
2020, and only 24,606 PLWH were receiving HIV-1 treatment of
whom 7,693 were PWID (Esbjörnsson et al., 2016).
In April 2019, a cluster of fourteen HIV-1 diagnoses in
children was reported in Ratodero, a town in Larkana district,
Pakistan (Siddiqui et al., 2020). By December 2019, 1,167 children
have been diagnosed with HIV-1 through a screening programme
established in response to the outbreak (Brenner et al., 2007).
Larkana has had three previous outbreaks of HIV, the first among
PWID in 2003, the second in 2016 among 12 children in a
paediatric hospital, and the third in 2016 among 56 individuals
in a renal dialysis unit (Brenner et al., 2007; Altaf et al.,
2016). These outbreaks were linked to poor infection prevention
control practices including reuse of needles and inadequate
blood screening.
For Pakistan, the outbreak in 2019 is unprecedented in terms
of predominantly affecting children and its magnitude: prior
to the outbreak, 1041 children had ever registered for HIV-1
care nationally over the past 13 years (Mir et al., 2020a). Early
during the outbreak, media reports implicated a local doctor who
had treated several of the infected children and who was later
diagnosed with HIV, in spreading HIV-1 infection (Abi-Habib
and Masood, 2019; Siddiqui et al., 2020).
In this study, we conducted a phylogenetic analysis to
investigate the HIV-1 outbreak subtype and the pattern and
source of transmission, and specifically whether this was a single-
source outbreak. Furthermore, we also analysed the sequences for
presence of drug resistance mutations (DRMs).
MATERIALS AND METHODS
Study Design and Setting
This study was embedded in an individually matched case-
control study that recruited 401 cases defined as children
aged 0–15 years who registered for HIV-1 care at the
Paediatric Treatment Center at Shaikh Zayed Children’s Hospital
(Siddiqui et al., 2020). This centre was established by the
Sindh AIDS Control Program in response to the outbreak.
Prior to the outbreak, the nearest paediatric HIV-1 services
were in the provincial capital, Karachi, situated more than
400 kilometres from Ratodero. Age-, sex-, and neighbourhood-
matched HIV-uninfected controls were also recruited. An
interviewer-administered questionnaire collected data on risk
factors for HIV-1 infection. A blood sample was collected
for Hepatitis B and C serology, and for HIV-1 phylogenetic
studies (in cases only). Written informed consent was obtained
from guardians and assent from participants. The study was
approved by the Aga Khan University Ethical Review Committee
(ERC# 2019-1536-4200). Prior to sample collection, written
informed consent was obtained from the guardians, and if the
child was able to understand the study procedures, a written
assent was obtained. The study objectives were explained to
the patient at the time of taking consent/assent and patients
were informed that their identities will remain confidential. The
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participants were also informed that they had the opportunity
to withdraw from the study at any given time and that this
would have no consequences on the treatment or the care that
they would receive.
DNA Amplification and HIV-1 Genotyping
Proviral DNA was extracted from blood samples obtained
from cases using Qiagen’s QIAamp DNA blood mini kit
according to the manufacturer’s instructions and stored at
-80◦C. The pol gene was amplified from each extracted DNA
sample using a two-step nested polymerase chain reaction
(PCR) strategy. Two sets of outer primers were used: Forward
(POLOF CAGCATGYCAGGGAGTRGGRGGACC, amino acid;
1832-1856, HXB2, IBF1 5′-AAATGATGACAGCATGTCAG
GGAGT-3′. nt 1823-1847, HXB2) and Reverse (IBR1 5′-AACTT
CTGTATATCATTGACAGTCCA-3′. nt 3303-3328, HXB2). The
first-round product was used as a template for the second
round with primer set, Forward (POLIF 5′-AGGCTAATTTT
TTAGGGAARATYTGGCCTTCC-3′. nt 2078-2109, amino
acid PR: 1–9; HXB2) and reverse (RTOUT3 5′-TATGTCATT
GACAGTCCAGCT-3′. nt 3300–3320, amino acid RT: 251–257
HXB2) (Tariq et al., 2018). PCR Mastermix (ABM) Bestaq (2X)
cat# G464 and Hotstart (2X) cat# G906 were used to prepare
a 25 ul reaction mixture, and 0.8 pmol and 0.6 pmol primer
used for the first and second round, respectively. Thermo
cycle conditions were as follows: denaturation at 95◦C for
5 min, followed by 40 cycles of denaturation at 95◦C for 1 min,
annealing at 50◦C for IBF1/IBR1 and 55◦C for POLOF/IBR1 sets
(round 1), 60◦C (round 2) for 20 s, extension at 72◦C for 1 min
with a final extension of at 72◦C for 7 min. The protocol was
run with positive and negative control to confirm results. The
amplicons underwent sequencing using the Sanger sequencing
platform (Macrogen, South Korea) and the sequences were




HIV-1 pol sequence data used in the study comprised of
either newly generated sequences (referred to as outbreak
sequences) or Pakistani HIV-1 pol sequences retrieved from the
Los Alamos HIV sequence database1 (referred to as published
Pakistani sequences representing Pakistani people who inject
drugs (PWID), heterosexuals, sex workers, and other individuals
with unknown transmission risk) (Kuiken et al., 2003). Outbreak
sequences and published Pakistani HIV-1 pol sequences (referred
to as the Pakistani dataset) were aligned with HIV-1 Group M
(subtypes A-K + Recombinants) subtype reference sequences1
using the MAFFT algorithm in Geneious Prime 2019 (Larkin
et al., 2007). Subtyping of each sequence was determined
by maximum-likelihood (ML) phylogenetic analysis in PhyML
using the general time-reversible substitution model with a
gamma-distributed rate variation and proportion of invariant
sites (GTR + 04 + I) (Guindon et al., 2010). Branch support
was estimated using the approximate likelihood ratio test
1http://www.hiv.lanl.gov
with the Shimodaira-Hasegawa-like procedure (SH-aLRT) in
PhyML, where SH-aLRT support values ≥0.90 were considered
significant (Guindon et al., 2010). Phylogenies were visualised
in FigTree v1.4.4.2
Cluster Analysis
To identify local transmission clusters, subtype-specific ML
phylogenies were reconstructed for the main/predominant
HIV-1 strains identified in the outbreak. The most similar non-
Pakistani sequences for each sequence in the Pakistani dataset
were retrieved from the NCBI GenBank and used as reference
sequences as previously described (Esbjörnsson et al., 2016;
Nazziwa et al., 2020; Nduva et al., 2020). The Pakistani dataset
and GenBank reference sequences were aligned by subtype or
CRF and subtype/CRF-specific phylogenies were reconstructed
in PhyML (Guindon et al., 2010). Monophyletic clusters having
aLRT-SH ≥0.90 and comprising ≥80% Pakistani sequences
were defined as Pakistani-specific clusters (Esbjörnsson et al.,
2016; Hassan et al., 2017; Nazziwa et al., 2020; Nduva
et al., 2020). Clusters were classified into dyads (2 sequences),
networks (3–14 sequences), or large clusters (>14 sequences)
(Esbjörnsson et al., 2016).
Estimating Dates of the Most Recent
Common Ancestor for Each Cluster
The dates of origin (time to the most recent common
ancestor; tMRCA) of the large Pakistani-specific HIV-1 clusters
were estimated using Bayesian Markov Chain Monte Carlo
(MCMC) inference in BEAST (v1.10.4) (Gill et al., 2020). All
Larkana outbreak sequences were sampled in 2019 and did not
independently have a sufficient temporal signal for inference
of the dates of origin. Hence, supplementary non-Pakistani
reference sequences (seven CRF02_AG and six sub-subtype A1
sequences), and Pakistani sequences from previous outbreaks
(33 CRF02_AG and 11 sub-subtype A1 sequences) sampled
from different years were used to inform the temporal signal
(assessed in TempEst v1.5.3) (Rambaut et al., 2016). Subtype-
specific Bayesian inferences were done in BEAST 1.10.4 using the
Bayesian Skygrid model with an uncorrelated lognormal relaxed
clock and inferred under the GTR + 04 + I substitution model
(Drummond et al., 2005; Baele et al., 2012; Gill et al., 2013;
Suchard et al., 2018). BEAST runs of 500 million generations were
performed, sampling every 50,000th iteration, and discarding the
first 10% of samples as burn-in. Convergence was determined
in Tracer v.1.7.0, defined as effective sample sizes (ESS) ≥200
(Suchard et al., 2018). Maximum clade credibility (MCC) trees
were summarised in Tree-Annotator v1.10.4 and visualised in
Figtree (v1.4.4).
Drug Resistance Mutation Analysis
Mutations in the HIV-1 pol gene (protease and reverse
transcriptase region) associated with resistance against protease
and reverse transcriptase inhibitors was determined using
the Stanford HIV-1 drug resistance database (Rhee et al., 2003),
2https://github.com/rambaut/figtree/releases
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and confirmed using the 2019 Update of the Drug Resistance
Mutations in HIV-1 by the International AIDS Society–
United States (Wensing et al., 2019). The DRMs were
also classified as those conferring high, intermediate, low,
and potential low-level resistance using the algorithm




Of the blood samples obtained from the 401 cases enrolled
in the case-control study, 344 were successfully amplified and
sequenced. The remaining 57 samples failed to amplify possibly
due to low viral load secondary to receiving antiretroviral
treatment or due to genomic diversity attributed to quasi-
species in an individual (Debyser et al., 1998; Gupta et al.,
2017). Out of 344 cases, socio-demographic information was
available for 321 sequences, while information for 23 cases was
missing. The median age of participants was three (IQR: 2–5)
years and 65% were male (Table 1). The majority (84.4%) were
taking ART at the time of sampling for a median period of
41 days (range: 22–192 days). The ART regimen comprised of
zidovudine, lamivudine, and nevirapine. Most participants lived
TABLE 1 | Characteristics of study participants.









Ratodero, Larkana 132 (41%)
Outside Ratodero but within Larkana district 141 (44%)
Shikarpur district 44 (13.7%)
Jafarabad district 1 (0.3%)
Khairpur district 1 (0.3%)





<30 days 93 (28.97%)
>30–180 days 175 (54.5%)
HCVand HBV co-infections
HBV positive 75 (23.4%)
HCV positive 26 (8%)
Maternal HIV-1 status
HIV-1 positive mother 28 (8.7%)
Mother’s HIV-1 status unknown 4 (1.2%)
in Ratodero, the epicentre of the outbreak, while the remainder
were from other areas of Larkana district and neighbouring
districts (Table 1).
Pakistani HIV-1 Sequence Dataset and
HIV-1 Subtypes and CRFs
Overall, we analysed 532 HIV-1 partial pol sequences in the
Pakistani dataset including outbreak sequences (N = 344) and
previously published sequences (N = 188). HIV-1 CRF02_AG
(N = 338, 63.5%) dominated the outbreak, followed by sub-
subtype A1 (N = 149, 28.0%). Additional subtypes found in the
outbreak were subtype C (N = 20, 3.8%), subtype G (N = 8, 1.5%),
CRF35_AD (N = 7, 1.3%), subtype B (N = 5, 0.9%), and subtype




ML phylogenies were reconstructed independently for
CRF02_AG (N = 338) and sub-subtypes A1 (N = 149),
which were the most prevalent HIV-1 strains in the outbreak.
The final reference dataset comprised of 310 non-Pakistani
reference sequences for CRF02_AG, and 382 for sub-subtype A1
remained. Overall, 291 (86.1% CRF02_AG outbreak sequences)
and 59 (40.0% sub-subtype A1 outbreak sequences) sequences
formed 17 supported Pakistani clusters (size range: 2–283
sequences per cluster). These 17 clusters included 9 dyads
(52.9% of all clusters), six networks (33.3%), and two large
clusters (11.8%, Table 2 and Figures 2A,B). Sub-subtype A1
clusters were more common (N = 13, 76.5%) as compared to
the CRF02_AG clusters (N = 4, 23.5%). Of the 344 outbreak
sequences, 312 (90.7%) were found in four distinct clusters.
More specifically, 283 sequences were found in one large
CRF02_AG cluster (Figure 2A), two sequences in a CRF02_AG
dyad (Figure 2A), 22 sequences in one large sub-subtype A1
cluster (Figure 2B), and four sequences in a sub-subtype A1
network (Figure 2B). HIV-1 clusters of outbreak sequences
showed no evidence of mixing with other HIV-1 risk groups
of Pakistan. Instead, the Pakistani sequences that were not
part of the outbreak formed an exclusive Pakistani cluster of
non-outbreak sequences (Table 2).
Estimation of Time to the Most Recent
Common Ancestor (tMRCA)
The tMRCAs were estimated for the two large clusters
(one CRF02_AG and one subtype A1 cluster) comprising of
the outbreak sequences. The median tMRCA of the CRF02_AG
cluster was estimated to 2016 (95% higher posterior density
[HPD] interval: 2015–2017), and the tMRCA of the sub-
subtype A1 cluster was estimated to be 2016 (95% HPD
interval: 2015–2018). In addition, the divergence time between
the outbreak sequences and that of other high-risk groups
in Pakistan, such as PWID, was dated to the year 1999
(95% HPD interval: 1994–2010) for the CRF02_AG cluster,
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FIGURE 1 | Maximum likelihood (ML)-based subtyping of HIV-1 sequences: ML-based phylogeny/subtyping of 532 HIV-1 sequences (including 344 outbreak
sequences from Larkana-Pakistan). Branch tips on the phylogenetic tree are coloured according to HIV CRF/subtype (Red: CRF_02AG; Blue: CRF_35AD, Green:
subtype A1; Sky Blue: subtype B; Brown: subtype C; Pink: subtype D; Yellow: subtype G; Black: reference sequences from the Los Alamos HIV database). Scale
bar units are nucleotide substitutions per site.
TABLE 2 | The number of Pakistani transmission clusters by cluster size, risk group, and shared drug resistance mutations.
Cluster name HIV-1 subtype Number of Tips Transmission group Number with shared DRM
Cluster_A1_1 A1 22 Paediatric RT:E138A; N = 21
Cluster_A1_2 A1 3 Paediatric RT:E138A; N = 3
Cluster_A1_3 A1 2 Unknown
Cluster_A1_4 A1 2 MSM/unknown
Cluster_A1_6 A1 2 PWID
Cluster_A1_7 A1 2 Unknown
Cluster_A1_8 A1 2 Unknown
Cluster_A1_9 A1 2 Unknown
Cluster_A1_10 A1 9 PWID/unknown
Cluster_A1_11 A1 2 Unknown
Cluster_A1_12 A1 5 Unknown
Cluster_A1_15 A1 3 MSM/unknown
Cluster_A1_16 A1 3 CWSW/unknown
Cluster_CRF02AG_1 CRF02_AG 283 Paediatric RT:K219Q; N = 5, RT:K103N; N = 19,
RT:E138A; N = 7, RT:V17; N = 10
Cluster_CRF02AG_2 CRF02_AG 4 Paediatric RT:E138A; N = 1, RT:V17; N = 2
Cluster_CRF02AG_3 CRF02_AG 2 Unknown
Cluster_CRF02AG_4 CRF02_AG 2 Unknown
Abbreviations: MSM, men who have sex with men; PWID, people who inject drugs; CWSW, female sex worker; Unknown, sequences lacking information on risk group or
transmission route; Outbreak, sequences collected from the 2019 Larkana outbreak; RT, HIV-1 reverse transcriptase gene.
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FIGURE 2 | Maximum-likelihood trees summarising clustering patterns of different risk groups in Pakistani: Trees represent (A) CRF02_AG, and (B) sub-subtype A1
transmission clusters, respectively. Each phylogeny is rooted at the midpoint, and branches are arranged in increasing node order. Branches with aLRT-SH support
≥0.9 are coloured red. Monophyletic clusters with aLRT-SH support ≥0.9 and which have ≥80% sequences from Pakistan are highlighted in grey. To enhance
cluster visualisation, some branches containing either reference sequences or Pakistani sequences that are not part of clusters have been collapsed (shown as black
triangles, with the recent end of the triangle indicating the latest sampling date). Branch tips within respective clusters are coloured as per cluster risk group (Bluish-
green: MSM; Sky blue: Pakistani PWID/other risk groups IDU; Yellow: Larkana paediatric sequences; and Black: Non-Pakistani Reference sequences). Scale bars
represent the genetic distance in substitutions per site in both phylogenies. As an overview, among CRF02_AG sequences, whereas PWID and other risk groups
formed small clusters (size range 2–4 sequences per cluster), paediatric sequences from the Larkana outbreak formed one large cluster (N = 283 sequences).
Likewise, among subtype A1 sequences, PWID and individuals from other risk groups formed several small clusters (size range, 2–9 sequences per cluster), whilst
paediatric sequences from the Larkana outbreak formed one large cluster (N = 22 sequences).
and 2004 (95% HPD interval: 1998–2014) for sub-subtype A1
cluster (Figure 3).
Drug Resistance Mutation Analysis
Drug resistance mutation analysis was conducted on both ART-
naïve (15.6%) and ART- experienced (84.4%) sequences from
the outbreak. Among ART naïve individuals, 15 (30%) had drug
resistance mutations (DRM); the most common of which were
the Reverse Transcriptase (RT):E138A (8.0%) and RT:K219Q
(8.0%) mutations. Among treatment-experienced individuals, the
most common mutations were RT:E138A (12.92%), RT:K219Q
(8.86%), and RT:K103N (6.64%). The DRMs RT:E138A and
RT:K103N confer resistance against non-nucleoside reverse
transcriptase inhibitors (NNRTI) rilpivirine and efavirenz,
respectively, while RT:K219Q is associated with resistance
against nucleoside reverse transcriptase inhibitors (NRTI)
zidovudine. Similarly, DRM PI:N88D, associated with resistance
against protease inhibitors (PI), such as atazanavir/ritonavir,
and tipranavir/ritonavir was observed in two treatment-
experienced participants, while DRMs PI:M46L, PI:D30N,
PI:N83D, PI:K43T, PI:G73S, PI:L33F were seen in one treatment-
experienced individual each (Table 3). No DRM against protease
inhibitors was observed in ART-naïve individuals. Analysis
also showed that 114 (42%) patients with DRMs belonged to
the drug-experienced group, while, 15 (30%) belonged to the
ART-naïve group (Table 3).
Next, sequences with any DRMs were analysed for clustering.
Among the 78 sequences from the Larkana outbreak with
prevalent drug resistance mutations, the DRM RT:K219Q was
shared between five sequences whereof all clustered together in
cluster_CRF02_AG_1 (Tables 2,3). The DRM RT:M184V was
found in two sequences – both in cluster_CRF02_AG_1. The
DRM RT:K103N was found among 21 sequences, whereof 19
sequences were found in cluster (cluster_CRF02_AG_1). The
two remaining sequences were not part of any cluster. The
DRM RT:E138A was found in 38 sequences of different subtypes
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FIGURE 3 | Maximum clade credibility trees used to date clusters: Maximum clade credibility (MCC) trees used to determine the time to the most recent common
ancestor of the Pakistani clusters. Trees represent (A) the large CRF02_AG outbreak cluster, and (B) the large sub-subtype A1 outbreak cluster, respectively. Nodes
representing divergence (tMRCA; median and 95% HPD estimates) between the Larkana outbreak and prevailing epidemic sequences (representing PWID and other
risk groups) are highlighted as asterisks only. Nodes representing the tMRCA of all outbreak sequences per sub-type/CRF have been highlighted using both an
arrow and an asterisk. Branches with posterior value ≥0.9 are coloured red.
including 21 sequences in cluster_A1_1, three sequences in
cluster A1_2, seven sequences in cluster_CRF02_AG_1, one
sequence in cluster_CRF02AG_2, and six sequences that were
not part of a cluster. The DRM RT:V179L was distributed among
10 sequences in cluster_CRF02AG_1, and two sequences in
cluster_CRF02AG_2 (Tables 2,3).
DISCUSSION
In this study, we determined the HIV-1 subtype distribution,
phylodynamics, and presence of HIV-1 drug-resistance
mutations of the 2019 HIV-1 outbreak among children in
Larkana, Pakistan. Seventeen distinct clusters were found among
the Larkana outbreak sequences, indicating that HIV-1 was
introduced from multiple sources rather than from a single
source, as previously suggested (Arif, 2019; Siddiqui et al., 2020).
A similar large-scale nosocomial HIV-1 outbreak was reported
in Libya 1998–1999 (Visco-Comandini et al., 2002), where a
monophyletic HIV-1 CRF02_AG cluster was identified among
children visiting the El-Fatih Children’s hospital in Benghazi.
The HIV-1 transmission in the Libyan children was suggested to
originate from contaminated intravenous injections (although
not from blood or blood products) (Visco-Comandini et al.,
2002). Similarly, the HIV-1 transmissions in the 2019 Larkana
outbreak were strongly associated with visits to both public
and private sector facilities, but not with a single healthcare
facility, and with receipt of infusions, injections and blood
transfusions (Mir et al., 2020b), implying transmission through
poor infection control practices. Some of the children had
HIV-1 positive mothers, raising the possibility of mother-to-
child HIV-1 transmission. However, the possibility of vertical
transmission could not be verified due to unavailability of
maternal samples. Taken together, our results indicate that
the Larkana outbreak was not the result of a single-source
transmission from one health care practitioner, but may have
resulted from through multiple sources at different health
facilities. Moreover, and as previously suggested, our results
indicate that poor infection prevention control is still present in
Larkana (Altaf, 2018).
The HIV-1 subtype analysis showed a high prevalence of
CRF02_AG and sub-subtype A1. This is consistent with previous
reports indicating sub-subtype A1 as the dominant circulating
subtype in Pakistan (Khan et al., 2018), whereas CRF02_AG has
shown increasing prevalence more recently (Chen et al., 2016).
A study reporting on the molecular epidemiology of HIV-1
in Pakistan suggested that sub-subtype A1 was introduced in
Pakistan 1989 (95% HPD: 1984–1994) (Chen et al., 2016).
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TABLE 3 | Classification of the Drug resistance mutations.








K219Q 4 (8.00) 1 (0.37) Major AZT
M184V 0 (0.00) 2 (0.74) Major ABC, 3TC





L210W 0 (0.00) 1 (0.37) Major AZT
K70R 0 (0.00) 2 (0.74) Major ABC, TDF, AZT
Y115F 0 (0.00) 1 (0.37) Major TDF, ABC






















K103N 2 (4.00) 19 (7.0) Major EFV, NVP
K101E 0 (0.00) 1 (0.37) Major/Minor NVP, EFV
E138A 4 (8.00) 35 (12.92) Major/Minor ETR, RPV
E138K 1 (2.00) 0 (0) Major/Minor EFV, NVP
E138G 0 (0.00) 1 (0.37) Major/Minor EFV, NVP






V179F 1 (2.00) 0 (0) Minor EFV, NVP
Y181C 0 (0.00) 1 (0.37) Major EFV, NVP
G190A 0 (0.00) 2 (0.74) Major/Minor EFV, NVP
V106I 1 (2.00) 2 (0.74) Minor NVP
F227C 0 (0.00) 1 (0.37) Major/Minor EFV, NVP
L234I 0 (0.00) 1 (0.37) Minor DOR
H221Y 0 (0.00) 1 (0.37) Major EFV, NVP
M46L 0 (0.00) 1 (0.37) Minor/Major LPV/r




















N83D 0 (0.00) 1 (0.37) Minor/Major ATV/r, TPV/r





L33F 0 (0.00) 1 (0.37) Minor LPV/r
The mutation classification column, indicates mutations that are classified as major or minor DRMs.
The last column shows the association of a mutation with resistance to a particular drug, as indicated in the Stanford drug resistance database and/or International AIDS
Society (IAS) 2019 report, respectively, while bold drug names indicate the major resistance by IAS 2019.
The abbreviations of the antiretroviral drugs are as follows: NRTI; zidovudine (AZT), lamivudine (3TC), abacavir (ABC), tenofovir (TDF), etravirine (ETR), rilpivirine
(RPV). NNRTI; efavirenz (EFV), nevirapine (NVP), doravirine (DOR). PI: lopinavir/ritonavir (LPV/r), nelfinavir (NFV), atazanavir/ritonavir (ATV/r), tipranavir/ritonavir (TPV/r),
Saquinavir/ritonavir (SQV/r). % = percentage of total participants.
After this introduction, sub-subtype A1 disseminated rapidly to
become the dominant HIV-1 strain (Chen et al., 2016). However,
no information exists about the introduction of CRF02_AG in
Pakistan, although it has been shown that the prevalence of
HIV-1 CRF02_AG infections are increasing – especially in high-
risk populations (Cholette et al., 2020). It is therefore possible
that HIV-1 CRF02_AG become the dominant HIV-1 strain in
Pakistan over time.
In our analysis, the tMRCA for the two large clusters
were both estimated to 2016 (CRF02_AG: 95% HPD interval:
2015–2017; A1: 95% HPD interval: 2015–2018), suggesting
ongoing HIV-1 transmissions several years prior to the 2019
outbreak. Interestingly, the estimated tMRCA of the two main
clusters coincides with the time of the previously reported HIV-1
outbreak in Larkana in 2016, which also occurred in a nosocomial
setting (Brenner et al., 2007; Siddiqui et al., 2020). Furthermore,
the majority (80%) of children identified in the outbreak had stage
3 or 4 disease (the moderately and severely symptomatic stage,
respectively, mostly associated with chronic to acute-chronic
infection) (Weinberg and Kovarik, 2010; Altaf et al., 2016),
indicating that some of the HIV-1 infections identified in the
2019 outbreak occurred a few years prior to 2019. Moreover, no
reference sequence from the global HIV-1 epidemic was found
in the Pakistani clusters, suggesting a localised HIV-1 epidemic.
It is possible that the transmission may have been ongoing
within healthcare settings, and the active screening programme
implemented by the provincial AIDS Control Program in
response to the initial diagnosis of HIV-1 in 14 children in 2019
identified these infections.
Phylogenetic analyses demonstrated no mixing between
the outbreak sequences and sequences previously obtained
from other high-risk groups in Pakistan. This was further
supported by dating of the outbreak and other Pakistani
clusters, indicating that the splitting time points between the
outbreak sequences and that of other high-risk groups in
Pakistan occurred between 1994 and 2012 (combined HPD
interval). This suggests that HIV-1 most likely were introduced
in Larkana between 10 and 27 years ago, and that the HIV-1
transmissions are now localised to certain regions of Larkana.
It is possible that HIV-1 arose from nosocomial routes through
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the widespread poor infection prevention control practices in
healthcare settings and contaminated blood (Cotton and Rabie,
2020; Mir et al., 2020a).
DRM analysis showed the presence of multiple DRMs
associated with resistance against reverse transcriptase inhibitors,
some of which were shared among sequences in the identified
clusters. The presence of shared DRMs may indicate transmission
of drug-resistant strains in outbreak sequences. The most
prevalence DRM identified among both ART-experienced and
ART-naïve individuals was RT:E138A which confers a high-level
resistance to NNRTIs such as Rilpivirine (Jeulin et al., 2014).
A high prevalence of this mutation has been seen previously in
ART-experienced PLWH in Pakistan (Shah et al., 2011) and when
found in the ART-naïve population, it may be present due to
transmission from non-compliant ART-experienced individuals.
The presence of DRMs, especially associated with resistance
to zidovudine and nevirapine, two out of three that are drugs
part of the ART regimen given to the children, may lead
to ART failure (correlating with failure to suppress the viral
load), and increase the possibility that these individuals may
acquire severe form of disease (Gupta-Wright et al., 2020).
A second DRM common in the outbreak sequences was the
RT:K219N mutation, a thymidine analogue mutation associated
with potential low-level resistance against zidovudine (Rhee
et al., 2003). Presence of DRMs and spread of strains containing
the mutation may lead to first line medications becoming
obsolete and present challenges due to limited availability of
second-line medications.
The strengths of the study are a relatively good sample
size, active collection of samples during the outbreak and
a comprehensive phylogenetic and phylodynamic analysis of
the Larkana outbreak to identify subtype distribution and
evolutionary relationship between sequences. The limitations
include amplification of a single gene (pol) only and short
sequence length. While the parent case-control study showed that
visits to both private and public sector health facilities and higher
frequency of injections was associated with HIV-1 infection, we
were unable to correlate the dyads and clusters with geographical
data. The lack of samples of all biological mothers, where the
mother was also HIV-positive, precluded investigation of the
role of mother-to-child transmission. Future studies based on
HIV-1 sequences sampled from different years (and HIV-1 risk
groups) could shed light on the effectiveness of ART programs
in Pakistan and provide an even more detailed picture of the
Larkana outbreak.
In conclusion, our study findings showed that the Larkana
paediatric outbreak did not originate from a single source
and is likely a consequence of ongoing transmission within
the high-risk groups of Larkana and introduced into the
exposed individuals at risk of acquiring through poor infection
prevention control practices in healthcare settings. Furthermore,
the presence of multiple drug resistance mutations in the
strains circulating in Larkana, especially to first-line ART
drugs, is worrying as it limits treatment options. Large-scale
transmission of resistant strains can hamper Pakistan’s efforts to
achieve the 90-90-90 goal (Maddali et al., 2016). These findings
highlight not only the urgent need to improve blood safety and
infection prevention control, but also the need for comprehensive
molecular epidemiological studies and molecular surveillance to
understand the distribution of different genotypes as well as
origin, transmission, and drug resistance patterns.
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